Literature DB >> 10632667

High prevalence of complement component C6 deficiency among African-Americans in the south-eastern USA.

Z Zhu1, T P Atkinson, K T Hovanky, S B Boppana, Y L Dai, P Densen, R C Go, J S Jablecki, J E Volanakis.   

Abstract

Complement component C6 is a part of the membrane attack complex that forms a pore-like structure in cell membranes following complement activation. Deficiency of terminal complement components including C6 predisposes individuals to infection with Neisseriae. Using polymerase chain reaction/single-strand conformation polymorphism analysis followed by DNA sequencing, we screened genomic DNA from 200 randomly chosen blacks and an equal number from whites for three loss-of-function C6 mutations. Ten blacks and two whites were found to be heterozygous for one of the mutations. Two of the mutations, 1195delC and 1936delG, were found exclusively in black individuals. A third previously undescribed mutation, 878delA, was found at equal frequency among the two groups. The difference between the two groups was significant (P = 0.027), indicating that C6 deficiency due to these three mutations is more common among blacks than whites in the local area, principally Jefferson County, Alabama. In addition, three previously undescribed point mutations, two of which result in amino acid substitutions, were identified within exon 6. A review of the county health department records over the past 6 years revealed a higher incidence of meningococcal meningitis in blacks due to serogroups Y and W-135 which paralleled the difference in the estimated prevalence of C6 deficiency. Among black residents of the county (n = 235 598) there were 15 cases of meningitis due to these two serogroups, compared with two cases in the white population (n = 422 604) (P = 0.002). We conclude that C6 deficiency is more common among blacks than whites in the south-eastern United States, with a frequency approaching 1 in 1600 black individuals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10632667      PMCID: PMC1905506          DOI: 10.1046/j.1365-2249.2000.01113.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

Review 1.  Complement deficiencies.

Authors:  H R Colten; F S Rosen
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

2.  Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups.

Authors:  C A Fijen; E J Kuijper; A J Hannema; A G Sjöholm; J P van Putten
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

3.  Complement activation and endotoxin levels in systemic meningococcal disease.

Authors:  P Brandtzaeg; T E Mollnes; P Kierulf
Journal:  J Infect Dis       Date:  1989-07       Impact factor: 5.226

4.  The molecular architecture of human complement component C6.

Authors:  R G DiScipio; T E Hugli
Journal:  J Biol Chem       Date:  1989-09-25       Impact factor: 5.157

Review 5.  The membrane attack complex of complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

6.  A physical map of the C6 and C7 complement component gene region on chromosome 5p13.

Authors:  M J Hobart; B A Fernie; R G DiScipio; P J Lachmann
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

Review 7.  Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency.

Authors:  S C Ross; P Densen
Journal:  Medicine (Baltimore)       Date:  1984-09       Impact factor: 1.889

8.  Host defense against Neisseria meningitidis requires a complement-dependent bactericidal activity.

Authors:  A Nicholson; I H Lepow
Journal:  Science       Date:  1979-07-20       Impact factor: 47.728

9.  Prevalence of congenital or acquired complement deficiency in patients with sporadic meningococcal disease.

Authors:  R T Ellison; P F Kohler; J G Curd; F N Judson; L B Reller
Journal:  N Engl J Med       Date:  1983-04-21       Impact factor: 91.245

10.  Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release.

Authors:  P J Lehner; K A Davies; M J Walport; A P Cope; R Würzner; A Orren; B P Morgan; J Cohen
Journal:  Lancet       Date:  1992-12-05       Impact factor: 79.321

View more
  11 in total

Review 1.  Molecular mechanisms of complement component C6 deficiency; a hypervariable exon 6 region responsible for three of six reported defects.

Authors:  A Orren
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

Review 2.  Deficiencies of the complement MAC II gene cluster (C6, C7, C9): is subtotal C6 deficiency of particular evolutionary benefit?

Authors:  R Würzner
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

Review 3.  Disease-causing mutations in genes of the complement system.

Authors:  Søren E Degn; Jens C Jensenius; Steffen Thiel
Journal:  Am J Hum Genet       Date:  2011-06-10       Impact factor: 11.025

4.  Complement factor 5 (C5) p.A252T mutation is prevalent in, but not restricted to, sub-Saharan Africa: implications for the susceptibility to meningococcal disease.

Authors:  C Franco-Jarava; D Comas; A Orren; M Hernández-González; R Colobran
Journal:  Clin Exp Immunol       Date:  2017-04-20       Impact factor: 4.330

5.  The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria.

Authors:  Theresa N Ramos; Meghan M Darley; Sebastian Weckbach; Philip F Stahel; Stephen Tomlinson; Scott R Barnum
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

6.  An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma.

Authors:  Hongquan Chen; Renxi Lin; Weibin Lin; Qing Chen; Dongjie Ye; Jing Li; Jinan Feng; Wenxiu Cheng; Mingfang Zhang; Yuanlin Qi
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996

7.  State-based surveillance to determine trends in meningococcal disease.

Authors:  Carmen Clarke; Sue Mallonee
Journal:  Public Health Rep       Date:  2009 Mar-Apr       Impact factor: 2.792

8.  Restricted genetic defects underlie human complement C6 deficiency.

Authors:  M A Dragon-Durey; V Fremeaux-Bacchi; J Blouin; D Barraud; W H Fridman; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

9.  Hierarchical genomic analysis of carried and invasive serogroup A Neisseria meningitidis during the 2011 epidemic in Chad.

Authors:  Kanny Diallo; Kadija Gamougam; Doumagoum M Daugla; Odile B Harrison; James E Bray; Dominique A Caugant; Jay Lucidarme; Caroline L Trotter; Musa Hassan-King; James M Stuart; Olivier Manigart; Brian M Greenwood; Martin C J Maiden
Journal:  BMC Genomics       Date:  2017-05-22       Impact factor: 3.969

Review 10.  Meningococcal disease and the complement system.

Authors:  Lisa A Lewis; Sanjay Ram
Journal:  Virulence       Date:  2013-10-08       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.